LL-Z1271α:: An interleukin-1β production inhibitor

被引:4
作者
Ichikawa, K
Inagaki, T
Kachi-Tonai, H
Kojima, Y
Nakamura, T
Nishida, H
Ueno, Y
Binding, P
Gabel, CA
Lucas, V
McNiff, PA
Kojima, N
机构
[1] Pfizer Pharmaceut Inc, Nagoya Labs, PGRD, Aichi 4702393, Japan
[2] Pfizer Inc, Sandwich Labs, PGRD, Sandwich CT13 9NJ, Kent, England
[3] Pfizer Inc, Groton Labs, PGRD, Groton, CT 06340 USA
关键词
D O I
10.1006/bbrc.2001.5458
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LL-Z12711 alpha, a fungal metabolite, dose-dependently inhibited interleukin-1 beta (IL-1 beta) production in lipopolysaccharide (LPS)-stimulated human whole blood. Oral administration of LL-Z1271 alpha to LPS-challenged mice caused significant lowering in the IL-1 beta levels in peritoneal cavity. Data presented suggest that LL-Z1271 alpha inhibits IL-1 beta production by a novel mechanism as the inhibitory activity was not due to effects on caspase-1 (IL-1 beta converting enzyme), the ATP-induced release mechanism or a lysosomotrophic effect. (C) 2001 Academic Press.
引用
收藏
页码:697 / 700
页数:4
相关论文
共 23 条
  • [1] Interleukin-1 receptor antagonist: Role in biology
    Arend, WP
    Malyak, M
    Guthridge, CJ
    Gabay, C
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 27 - 55
  • [2] INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    [J]. ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 : 167 - 227
  • [3] MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME
    CERRETTI, DP
    KOZLOSKY, CJ
    MOSLEY, B
    NELSON, N
    VANNESS, K
    GREENSTREET, TA
    MARCH, CJ
    KRONHEIM, SR
    DRUCK, T
    CANNIZZARO, LA
    HUEBNER, K
    BLACK, RA
    [J]. SCIENCE, 1992, 256 (5053) : 97 - 100
  • [4] Chantry D, 1989, Biotechnol Ther, V1, P361
  • [5] INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS
    COMINELLI, F
    NAST, CC
    CLARK, BD
    SCHINDLER, R
    LLERENA, R
    EYSSELEIN, VE
    THOMPSON, RC
    DINARELLO, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) : 972 - 980
  • [6] Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
  • [7] INFLAMMATORY CYTOKINES - INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR AS EFFECTOR MOLECULES IN AUTOIMMUNE-DISEASES
    DINARELLO, CA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (06) : 941 - 948
  • [8] STRUCTURE OF A C17 ANTIFUNGAL TERPENOID FROM AN UNIDENTIFIED ACROSTALAGMUS SPECIES
    ELLESTAD, GA
    EVANS, RH
    KUNSTMANN, MP
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (08) : 2134 - +
  • [9] Ferrari D, 1997, J IMMUNOL, V159, P1451
  • [10] GEIGER T, 1993, CLIN EXP RHEUMATOL, V11, P515